1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Nielsen, K.J. Thomas, L. Lewis, R.J. Alewood, P.F. Craik, D.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 263 297 310 10.1006/jmbi.1996.0576 8913308 A consensus structure for omega-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: comparison of MVIIA, SVIB and SNX-202. 1996 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2750.234 SVIB 1 man polymer OMEGA-CONOTOXIN SVIB no yes CKLKGQSCRKTSYDCCSGSCGRSGKC(NH2) CKLKGQSCRKTSYDCCSGSCGRSGKCX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n striated cone Conus sample 6493 Conus striatus pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1997-08-12 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1996-08-02 REL REL LOW E AND FEW VIOLATIONS OF EXPERIMENTAL RESTRAINTS 50 15 NOESY TOCSY DQF-COSY E-COSY 3. 293 K CHARM22 A TOTAL OF 50 INITIAL STRUCTURES WERE CALCULATED USING A SIMULATED ANNEALING PROGRAM AS SUPPLIED WITH X-PLOR 3.1. THE FINAL 20 STRUCTURES WITH THE LOWEST OVERALL ENERGIES AND FEWEST VIOLATIONS OF NOE AND DIHEDRAL RESTRAINTS WERE ENERGY MINIMIZED IN X-PLOR USING THE CHARMM FORCEFIELD [BROOKS ET AL. (1983) J. COMPUT. CHEM., VOL. 4 187-217.] MD/SIMULATED ANNEALING BRUNGER refinement X-PLOR 3.1 structure solution X-PLOR 500 Bruker ARX CYS 1 n 1 CYS 1 A LYS 2 n 2 LYS 2 A LEU 3 n 3 LEU 3 A LYS 4 n 4 LYS 4 A GLY 5 n 5 GLY 5 A GLN 6 n 6 GLN 6 A SER 7 n 7 SER 7 A CYS 8 n 8 CYS 8 A ARG 9 n 9 ARG 9 A LYS 10 n 10 LYS 10 A THR 11 n 11 THR 11 A SER 12 n 12 SER 12 A TYR 13 n 13 TYR 13 A ASP 14 n 14 ASP 14 A CYS 15 n 15 CYS 15 A CYS 16 n 16 CYS 16 A SER 17 n 17 SER 17 A GLY 18 n 18 GLY 18 A SER 19 n 19 SER 19 A CYS 20 n 20 CYS 20 A GLY 21 n 21 GLY 21 A ARG 22 n 22 ARG 22 A SER 23 n 23 SER 23 A GLY 24 n 24 GLY 24 A LYS 25 n 25 LYS 25 A CYS 26 n 26 CYS 26 A NH2 27 n 27 NH2 27 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N GLY 21 A N GLY 21 A O LYS 25 A O LYS 25 A O GLY 24 A O GLY 24 A N CYS 8 A N CYS 8 1 7.14 1.10 114.20 121.34 A A A CA CB SG CYS CYS CYS 8 8 8 N 3 7.58 1.10 114.20 121.78 A A A CA CB SG CYS CYS CYS 8 8 8 N 1 A SER 19 -161.19 -39.75 1 A CYS 20 -16.35 122.03 1 A ARG 22 -95.45 34.54 1 A SER 23 77.48 39.26 2 A THR 11 73.79 -16.18 3 A TYR 13 54.49 19.67 3 A SER 17 -69.58 0.85 4 A CYS 8 -160.07 -168.71 4 A LYS 10 -48.87 152.73 4 A THR 11 49.56 16.41 4 A TYR 13 54.53 17.96 4 A ARG 22 -95.42 33.19 4 A SER 23 59.83 83.38 6 A SER 12 -154.12 51.88 6 A TYR 13 -24.45 -57.17 6 A CYS 20 -19.94 135.14 6 A ARG 22 -95.28 32.02 6 A SER 23 61.26 74.03 7 A THR 11 58.37 8.37 7 A SER 17 -69.48 0.67 7 A ARG 22 -95.48 33.40 7 A SER 23 70.97 30.21 8 A THR 11 65.19 -8.70 8 A ARG 22 -95.26 33.00 8 A SER 23 83.05 36.85 9 A THR 11 68.36 -1.89 9 A TYR 13 55.86 17.75 9 A CYS 20 -34.30 144.23 9 A SER 23 85.69 19.04 10 A THR 11 48.90 15.99 10 A CYS 20 -27.23 132.59 10 A ARG 22 -95.23 32.35 10 A SER 23 80.41 32.03 11 A THR 11 75.01 -20.92 11 A TYR 13 49.08 28.50 11 A ARG 22 -95.51 32.85 12 A SER 19 -156.46 -15.81 12 A CYS 20 -39.07 129.75 12 A ARG 22 -95.34 32.95 13 A THR 11 48.18 14.93 13 A CYS 20 -38.28 142.82 13 A ARG 22 -95.54 35.07 13 A SER 23 62.15 64.10 14 A CYS 8 -160.12 -166.95 14 A THR 11 76.28 -25.87 14 A SER 23 120.25 33.77 15 A THR 11 77.66 -28.07 15 A CYS 20 -34.40 140.68 15 A ARG 22 -95.29 31.89 15 A SER 23 59.63 79.76 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 SVIB N-TYPE CALCIUM CHANNEL BLOCKER, OMEGA-CONOTOXIN MVIIA NMR, 15 STRUCTURES 1 Y N A LYS 10 A LYS 10 HELX_P A SER 12 A SER 12 5 1 3 disulf 2.020 A CYS 1 A SG CYS 1 1_555 A CYS 16 A SG CYS 16 1_555 disulf 2.022 A CYS 8 A SG CYS 8 1_555 A CYS 20 A SG CYS 20 1_555 disulf 2.016 A CYS 15 A SG CYS 15 1_555 A CYS 26 A SG CYS 26 1_555 covale 1.308 A NH2 27 A N NH2 27 1_555 A CYS 26 A C CYS 26 1_555 NEUROTOXIN CONUS STRIATUS PEPTIDE SPECIFIC TO P/Q-TYPE VOLTAGE SENSITIVE CALCIUM CHANNEL, NEUROTOXIN CXO6B_CONST UNP 1 1 P28881 CKLKGQSCRKTSYDCCSGSCGRSGKC 1 26 1MVJ 1 26 P28881 A 1 1 26 3 anti-parallel anti-parallel A CYS 20 A CYS 20 A GLY 21 A GLY 21 A GLY 24 A GLY 24 A CYS 26 A CYS 26 A GLN 6 A GLN 6 A CYS 8 A CYS 8 BINDING SITE FOR RESIDUE NH2 A 27 Software 4 A SER 19 A SER 19 4 1_555 A CYS 20 A CYS 20 4 1_555 A LYS 25 A LYS 25 4 1_555 A CYS 26 A CYS 26 4 1_555 1 P 1